NCT01010724View on ClinicalTrials.gov

Efficacy and Safety Study on bIAP

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Coronary Artery DiseaseEndotoxin-mediated Complications From Cardiopulmonary Bypass Surgery
Interventions
DRUG

bIAP

DRUG

Placebo

Trial Locations (1)

5623EJ

Catharina hospital, dept. of Cardiothoracic Surgery, Eindhoven

Sponsors
All Listed Sponsors
collaborator

Alloksys Life Sciences B.V.

INDUSTRY

lead

Catharina Ziekenhuis Eindhoven

OTHER

NCT01010724 - Efficacy and Safety Study on bIAP | Biotech Hunter | Biotech Hunter